Stay updated on Durvalumab Combinations in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Combinations in NSCLC Clinical Trial page.

Latest updates to the Durvalumab Combinations in NSCLC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded Revision: v3.4.2 to the history and removed the earlier funding-lapse notice (v3.4.1).SummaryDifference0.5%

- Check21 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and updated the revision to v3.4.1 (replacing v3.4.0).SummaryDifference0.5%

- Check28 days agoChange DetectedAdded a 'Show glossary' option and color-coded legends explaining additions (green) and deletions (red). Updated the revision tag from v3.3.4 to v3.4.0 and added No FEAR Act Data.SummaryDifference0.7%

- Check42 days agoChange DetectedMinor revision history updates: v3.3.4 added and v3.3.3 removed; these do not affect study content, status, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedThe page history shows a new 'Revision: v3.3.3' entry, and the 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' items have been removed. These are minor site-wide updates to footer/metadata and do not affect study information or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check91 days agoChange DetectedThe page history now includes a new revision entry v3.3.2 and removes v3.2.0 from the history section; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Durvalumab Combinations in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Combinations in NSCLC Clinical Trial page.